Nuclear Capacity Expansion Beyond 10 kt: Metropolis Works targets greater than 10 kilotonnes of UF6 production in 2026, approximately 20% above 2024 planned capacity.²¹ Management has retained an EPC firm to evaluate brick-and-mortar capacity additions and is in active customer discussions about long-term supply commitments. Even at current contracted volumes, management projects double-digit EBITDA CAGR for the nuclear business from 2026 through 2030, driven by step-up pricing on maturing backlog contracts. An additional capacity tranche would extend that growth runway materially.⁹
HFO Aftermarket Maturation: The installed base of residential and commercial HVAC units using HFO blends is growing rapidly as OEM factories complete the regulatory transition. Aftermarket servicing requires exact replacement refrigerant and carries structurally higher margins than OEM supply. The aftermarket represents approximately 50% of refrigerant mix today and will expand as new HFO equipment ages into its first service cycle, providing a margin tailwind that management expects to be the primary driver of refrigerant segment margin recovery through 2026 and beyond.¹⁰
Spokane Semiconductor Expansion: The $200 million investment in Spokane Valley will double sputtering target capacity by end of 2029 and reduce lead times by approximately 25%.¹⁹ As AI accelerator chip production expands and advanced packaging architectures multiply the number of sputtering cycles per wafer, this capacity positions Solstice to capture a larger share of an expanding market without requiring incremental customer re-qualification.
Spectra Defense and Medical Fiber: Safety and Defense Solutions is investing in Spectra production capacity to meet demand from armor systems and medical fiber applications. Elevated global defense spending and growing use of high-strength fibers in vehicle armor and personal protection equipment provide a multi-year demand tailwind.¹⁰
Selective M&A: With approximately $1.5 billion in total liquidity and net leverage of 1.5 times EBITDA, Solstice has stated M&A as an explicit capital allocation priority.⁹ As an independent company, management can pursue acquisitions in specialty fluorochemicals, advanced materials, or adjacent nuclear services that were structurally constrained as a Honeywell business unit.

"Our backlog is, you know, can be anywhere from three to five years, and then we have a spot market where we'll keep a little bit of capacity for the open market, which obviously gets premium pricing. So when you combine all those factors, and you look through 2030, you'll just see incrementally growing pricing."
— David Sewell, President & CEO, Q4 FY2025 Earnings Call⁹

Solstice Advanced Materials: Specialty Chemistry at the Intersection of Nuclear, AI Chips, and Next-Generation Refrigerants

The Power Delivery Gap